Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis

被引：0
|
作者：
Sibel Ada
Sibel Ersan
Aykut Sifil
Mehtat Unlu
Efsun Kolatan
Mehmet Sert
Sulen Sarioglu
Osman Yilmaz
Taner Camsari
机构：
[1] Dokuz Eylul University Hospital,Division of Nephrology, Department of Internal Medicine
[2] Dokuz Eylul University Hospital,Department of Pathology
[3] Dokuz Eylul University Hospital,Department of Laboratory Animals Science
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Fibrosis; Growth factors; Peritoneal dialysis; Peritoneal membrane;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2047 / 2051
页数：4
相关论文
共 50 条
  • [1] Effect of bevacizumab, a vascular endothelial growth factor inhibitor, on a rat model of peritoneal sclerosis
    Ada, Sibel
    Ersan, Sibel
    Sifil, Aykut
    Unlu, Mehtat
    Kolatan, Efsun
    Sert, Mehmet
    Sarioglu, Sulen
    Yilmaz, Osman
    Camsari, Taner
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (12) : 2047 - 2051
  • [2] Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model
    Abuohashish, Hatem
    Alamri, Abdulaziz
    Shahin, Suliman
    Almazrou, Dalal
    Alkhamis, Taleb
    Omar, Omar
    HELIYON, 2023, 9 (05)
  • [3] Invasive aspergillosis associated with bevacizumab, a vascular endothelial growth factor inhibitor
    Williams, John
    Lim, Robert
    Tambyah, Paul
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (06) : 549 - 550
  • [4] Effect of bevacizumab and everolimus combination treatment on peritoneal sclerosis in an experimental rat model
    Mert, Gizem Sultan Acikgoz
    Ceri, Mevlut
    Demirkan, Nese Calli
    Sahin, Barbaros
    Mert, Mehmet
    Dursun, Belda
    THERAPEUTIC APHERESIS AND DIALYSIS, 2021, 25 (03) : 323 - 330
  • [5] Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface Malignancies
    Chia, Claramae Shulyn
    Glehen, Olivier
    Bakrin, Naoual
    Decullier, Evelyne
    You, Benoit
    Gilly, Francois Noel
    Passot, Guillaume
    ANNALS OF SURGICAL ONCOLOGY, 2015, 22 : S880 - S887
  • [6] Intraperitoneal Vascular Endothelial Growth Factor: A Prognostic Factor and the Potential for Intraperitoneal Bevacizumab Use in Peritoneal Surface Malignancies
    Claramae Shulyn Chia
    Olivier Glehen
    Naoual Bakrin
    Evelyne Decullier
    Benoit You
    François Noël Gilly
    Guillaume Passot
    Annals of Surgical Oncology, 2015, 22 : 880 - 887
  • [7] Vascular endothelial growth factor A as a marker of bevacizumab in glioblastoma
    You, Weir Chiang
    Lin, Jin-Ching
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [8] ECMO for Severe Refractory Pulmonary Hypertension Associated with Vascular Endothelial Growth Factor Inhibitor Bevacizumab
    Kim, A. I.
    Abadir, S.
    Mehta, J. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [9] The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction
    Lee, MC
    El-Sakka, AI
    Graziottin, TM
    Ho, HC
    Lin, CS
    Lue, TF
    JOURNAL OF UROLOGY, 2002, 167 (02): : 761 - 767
  • [10] Effect of thalidomide on the expression of vascular endothelial growth factor in a rat model of liver regeneration
    Hung, Kuo-Chen
    Hsieh, Pei-Min
    Yang, Kun-Lin
    Lin, Kai-Jen
    Chen, Yaw-Sen
    Hung, Chih-Hsin
    ONCOLOGY LETTERS, 2013, 5 (03) : 852 - 856
12345